Implementation Challenges for Risk-Stratified Screening in the Era of Precision Medicine

JAMA Oncol. 2018 Nov 1;4(11):1484-1485. doi: 10.1001/jamaoncol.2018.1940.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Breast Neoplasms*
  • Cost-Benefit Analysis
  • Early Detection of Cancer
  • Humans
  • Mass Screening
  • Precision Medicine*